| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +0% |
| Net profit | SEK 0 | — |
| Total assets | SEK 51K | +0% |
| Equity | SEK 51K | +0% |
| Employees | 0 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | — | 49 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 23 | −283 | −48 | −1 | −1 | −1 | −1 |
| Depreciation & amort. | −21 | −42 | −42 | −42 | −42 | −21 | −0 |
| EBIT | 2 | −325 | −90 | −43 | −43 | −22 | −1 |
| Net financials | — | — | — | — | — | — | — |
| Profit before tax | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 685 | 1 747 | 244 | 201 | 158 | 51 | 51 |
| Equity | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
| Long-term debt | 1 538 | 1 638 | 193 | 150 | 107 | 0 | 0 |
| Short-term debt | 96 | 58 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 1 634 | 1 696 | 193 | 150 | 107 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JD Chief Auditor | Chief Auditor | 2023 | — | — |
JO Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Surgical Science Sweden AB | Company | 100.0% | 100.0% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Johan Daniel Haglund | Chief Auditor | 0 companies |
| Jan Olof Malm | Chief Auditor | 0 companies |
| Jan Olof Roland Bengtsson | Chairman | 0 companies |
| Jonas Olof Nilsagård | Board of Directors | 0 companies |
| Anna Sofia Ahlberg | Deputy Board Member | 0 companies |
| Gisli Hennermark | Board of Directors | 0 companies |